The 2025 European Society of Cardiology/European Association of Cardiothoracic Surgery joint guidelines for the management of valvular heart disease: Revolution or evolution?
Polish Heart Journal · 2026
DOI: 10.33963/v.phj.111320 ↗Kurz gefasst
Leitlinie in der Zeitschrift Polish Heart Journal, 2026. Verfasst von Wojciech Wojakowski und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland. wwojakowski@sum.edu.pl. Hauptthemen laut MEDLINE: Heart Valve Diseases, Practice Guidelines as Topic.
Abstract (Originalsprache)
The 2025 European Society of Cardiology (ESC)/European Association for Cardio-Thoracic Surgery guidelines for the management of valvular heart disease (VHD), presented at the ESC Congress in Madrid, update the 2021 document and respond to the rapid growth of evidence from randomized trials, meta-analyses, and large registries. Developed by a multidisciplinary Heart Team including patient representatives, the guidelines emphasize patient-centered “lifetime” management, shared decision-making, and treatment at high-volume expert Heart Valve Centers, especially for complex surgical and transcatheter procedures. The scope has been broadened to address cancer and radiation-associated VHD, cardiogenic shock and acute heart failure (HF), multiple and mixed VHD, and sex-specific issues. Key changes in indications for imaging, treatment, and follow-up of VHD are discussed in the perspective of evidence-based medicine. Key updates include earlier intervention in severe, high-gradient, asymptomatic aortic stenosis, refined age thresholds for transfemoral transcatheter aortic valve implantation, and its use in bicuspid aortic stenosis and aortic regurgitation in high-risk or inoperable patients. Recommendations for secondary mitral regurgitation (MR) distinguish atrial from ventricular mechanisms and upgrade mitral transcatheter edge-to-edge repair (TEER) to class I in selected cases of ventricular secondary MR. At the same time, surgery remains first line for primary MR, with defined triggers for early repair and emerging roles for TEER and TEER in high-risk patients. The document also strengthens guidance on tricuspid interventions and structured assessment of right ventricular dysfunction, and simplifies antithrombotic strategies, including restricted use of dual antiplatelet therapy after transcatheter aortic valve implantation in patients without another indication for oral anticoagulation. Implementing these recommendations should streamline care pathways and reduce the burden of VHD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland. wwojakowski@sum.edu.pl.
- Division of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland.
- Department of Cardiology, Bern University Hospital, Bern, Switzerland.
Zitieren
APA
Wojakowski, W., Tendera, M., & Praz, F. (2026). The 2025 European Society of Cardiology/European Association of Cardiothoracic Surgery joint guidelines for the management of valvular heart disease: Revolution or evolution?. Polish Heart Journal. https://doi.org/10.33963/v.phj.111320
Vancouver
Wojakowski W, Tendera M, Praz F. The 2025 European Society of Cardiology/European Association of Cardiothoracic Surgery joint guidelines for the management of valvular heart disease: Revolution or evolution?. Polish Heart Journal. 2026. doi:10.33963/v.phj.111320
BibTeX
@article{Wojakowski2026,
author = {Wojakowski, Wojciech and Tendera, Michał and Praz, Fabien},
title = {The 2025 European Society of Cardiology/European Association of Cardiothoracic Surgery joint guidelines for the management of valvular heart disease: Revolution or evolution?},
journal = {Polish Heart Journal},
year = {2026},
doi = {10.33963/v.phj.111320}
}
EUVIMED